Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?

Authors :: Saleem, B.
Mackie, S.
Quinn, M.
Nizam, S.
Hensor, E.
Jarrett, S.
Conaghan, P.G.
Emery, P.
Source :: Annals of the Rheumatic Diseases. August, 2008, Vol. 67 Issue 8, p1178, 3 p.
Publication Year :: 2008

Subjects :: Rheumatoid arthritis -- Prevention
Rheumatoid arthritis -- Research
Tumor necrosis factor -- Physiological aspects
Methotrexate -- Dosage and administration
Methotrexate -- Patient outcomes
Methotrexate -- Research
Prognosis -- Research
Health

Tools